Nature, Published online: 03 January 2024; doi:10.1038/d41586-023-03988-2
Infections caused by drug-resistant strains of the bacterium Acinetobacter baumannii have been hard to treat in the clinic. A new class of antibiotics has been identified with the potential to tackle these microbes.
Source link